Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

744

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

October 29, 2022

Study Completion Date

February 26, 2023

Conditions

Major Depressive Disorder

Interventions

DRUG

Sertraline

Sertraline (200 mg/day) capsule

DRUG

Escitalopram

Escitalopram (10 mg/day) capsule

Trial Locations (1)

KRL Hospital, Islamabad

All Listed Sponsors

collaborator

Khyber Medical College, Peshawar

OTHER

collaborator

Quaid-e-Azam Medical College

OTHER

collaborator

Dow University of Health Sciences

OTHER

lead

KRL Hospital, Islamabad

OTHER